Clinical study on biapenem in patients with respiratory tract infections

Abstract

Biapenem (BIPM), a new carbapenem antibiotic, was administered to 20 patients with respiratory tract infections (RTI). A clinical evaluation of BIPM was carried out in 17 patients, 16 with pneumonia and 1 with chronic bronchitis.
The clinical efficacy rate was 76.5%. Six organisms were isolated out of 6 patients. The eradication rate was 100%.
No side effects were observed. Abnormal laboratory findings were observed in 2 episodes.